AddLife AB (publ)

OM:ALIF B Stock Report

Market Cap: SEK 20.8b

AddLife Valuation

Is ALIF B undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Future Cash Flow Value

  • Significantly Below Future Cash Flow Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Future Cash Flow Value

What is the Fair Price of ALIF B when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Future Cash Flow Value: ALIF B (SEK170.9) is trading below our estimate of future cash flow value (SEK229.64)

Significantly Below Future Cash Flow Value: ALIF B is trading below future cash flow value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ALIF B?

Key metric: As ALIF B is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for ALIF B. This is calculated by dividing ALIF B's market cap by their current earnings.
What is ALIF B's PE Ratio?
PE Ratio36.7x
EarningsSEK 568.00m
Market CapSEK 20.83b

Price to Earnings Ratio vs Peers

How does ALIF B's PE Ratio compare to its peers?

The above table shows the PE ratio for ALIF B vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average42.8x
MCAP MedCap
34.3x14.86%SEK 7.7b
GENO Genovis AB (publ.)
52.6x34.68%SEK 1.3b
BIOG B BioGaia
36x18.17%SEK 11.9b
CAMX Camurus
48.4x34.59%SEK 33.0b
ALIF B AddLife
36.7x15.37%SEK 20.8b

Price-To-Earnings vs Peers: ALIF B is good value based on its Price-To-Earnings Ratio (36.7x) compared to the peer average (42.8x).

Historical Price to Earnings Ratio

Historical Price to Earnings Ratio compares a stock's price to its earnings over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Earnings Ratio vs Industry

How does ALIF B's PE Ratio compare vs other companies in the European Life Sciences Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
ALIF B 36.7xIndustry Avg. 36.2xNo. of Companies3PE020406080100+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: ALIF B is expensive based on its Price-To-Earnings Ratio (36.7x) compared to the Global Life Sciences industry average (36.2x).

Price to Earnings Ratio vs Fair Ratio

What is ALIF B's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ALIF B PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio36.7x
Fair PE Ratio34.9x

Price-To-Earnings vs Fair Ratio: ALIF B is expensive based on its Price-To-Earnings Ratio (36.7x) compared to the estimated Fair Price-To-Earnings Ratio (34.9x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst ALIF B forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentSEK 170.90
SEK 194.00
+13.52%
6.28%SEK 205.00SEK 177.00n/a3
Jun ’27SEK 143.40
SEK 193.00
+34.59%
6.10%SEK 205.00SEK 177.00n/a3
May ’27SEK 142.90
SEK 193.00
+35.06%
6.10%SEK 205.00SEK 177.00n/a3
Apr ’27SEK 146.00
SEK 187.50
+28.42%
5.07%SEK 197.00SEK 178.00n/a2
Mar ’27SEK 154.20
SEK 193.50
+25.49%
8.01%SEK 209.00SEK 178.00n/a2
Feb ’27SEK 136.50
SEK 191.50
+40.29%
11.23%SEK 213.00SEK 170.00n/a2
Jan ’27SEK 159.10
SEK 208.50
+31.05%
2.16%SEK 213.00SEK 204.00n/a2
Dec ’26SEK 187.00
SEK 213.50
+14.17%
4.45%SEK 223.00SEK 204.00n/a2
Nov ’26SEK 205.40
SEK 213.50
+3.94%
4.45%SEK 223.00SEK 204.00n/a2
Oct ’26SEK 177.00
SEK 200.00
+12.99%
3.50%SEK 207.00SEK 193.00n/a2
Sep ’26SEK 180.20
SEK 196.50
+9.05%
1.78%SEK 200.00SEK 193.00n/a2
Aug ’26SEK 169.60
SEK 196.50
+15.86%
1.78%SEK 200.00SEK 193.00n/a2
Jul ’26SEK 187.50
SEK 196.50
+4.80%
1.78%SEK 200.00SEK 193.00n/a2
Jun ’26SEK 184.40
SEK 184.00
-0.22%
0.54%SEK 185.00SEK 183.00SEK 143.402
May ’26SEK 183.00
SEK 178.50
-2.46%
2.52%SEK 183.00SEK 174.00SEK 142.902
Apr ’26SEK 149.70
SEK 184.00
+22.91%
2.17%SEK 188.00SEK 180.00SEK 146.002
Mar ’26SEK 163.50
SEK 184.00
+12.54%
2.17%SEK 188.00SEK 180.00SEK 154.202
Feb ’26SEK 151.50
SEK 166.00
+9.57%
0.60%SEK 167.00SEK 165.00SEK 136.502
Jan ’26SEK 137.30
SEK 165.50
+20.54%
0.30%SEK 166.00SEK 165.00SEK 159.102
Dec ’25SEK 133.10
SEK 165.50
+24.34%
0.30%SEK 166.00SEK 165.00SEK 187.002
Nov ’25SEK 136.00
SEK 165.50
+21.69%
0.30%SEK 166.00SEK 165.00SEK 205.402
Oct ’25SEK 159.50
SEK 168.00
+5.33%
1.79%SEK 171.00SEK 165.00SEK 177.002
Sep ’25SEK 163.00
SEK 168.00
+3.07%
1.79%SEK 171.00SEK 165.00SEK 180.202
Aug ’25SEK 156.00
SEK 168.00
+7.69%
1.79%SEK 171.00SEK 165.00SEK 169.602
Jul ’25SEK 125.30
SEK 142.50
+13.73%
2.46%SEK 146.00SEK 139.00SEK 187.502
Jun ’25SEK 114.40
SEK 137.00
+19.76%
1.46%SEK 139.00SEK 135.00SEK 184.402
SEK 194
Fair Value
11.9% undervalued intrinsic discount
3
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/29 00:08
End of Day Share Price 2026/06/29 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

AddLife AB (publ) is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Karl NorénDanske Bank
Robert RedinDNB Carnegie
Gustav BernebladNordea Markets